These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1010046)
1. [Preparation of solutions for sulfanilamide preparation injections in pharmacy and in pharmaceutical manufacture]. Voropanov EI Farmatsiia; 1976; 25(4):24-8. PubMed ID: 1010046 [No Abstract] [Full Text] [Related]
2. [Study of the decomposition process of sulfanilamide preparations in solution during sterilization and storage]. Voropanov EI Farmatsiia; 1976; 25(1):35-8. PubMed ID: 1253999 [No Abstract] [Full Text] [Related]
3. The compatibility and stability of midazolam and dexamethasone in infusion solutions. Good PD; Schneider JJ; Ravenscroft PJ J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacy preparation of injection and other sterile solutions]. Chirkov AI Voen Med Zh; 1982 May; (5):55-6. PubMed ID: 7101801 [No Abstract] [Full Text] [Related]
6. Re: Hexsel, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Hexsel DM; Alencar de Castro I; Zechmeister D; Almeida do Amaral A Dermatol Surg; 2004 May; 30(5):823. PubMed ID: 15099336 [No Abstract] [Full Text] [Related]
7. [Method of stabilizing an aminazine solution for injections]. Ruzhitskiĭ DM; Ruzhitskaia OD Farm Zh; 1974; 29(6):78-80. PubMed ID: 4464082 [No Abstract] [Full Text] [Related]
8. [Studies of the stability and preparation of 2 per cent L-adrenaline solutions for treatment of wide angle glaucoma]. Trose D; Wagner C; Nebel M Pharm Prax; 1970; 3():62-3. PubMed ID: 5430541 [No Abstract] [Full Text] [Related]
9. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
10. The effect of antioxidants on the photolysis of aqueous sulfacetamide and sulfanilamide solutions. Ahmad T; Ahmad I Pol J Pharmacol Pharm; 1983; 35(1):69-75. PubMed ID: 6889188 [TBL] [Abstract][Full Text] [Related]
11. Physico-chemical analysis of several injectable drug in ready-to-use infusion after microwave freeze-thaw treatment and final storage at 5 ± 3 °C. Hecq JD; Vanbeckbergen D; Jamart J; Galanti L Ann Pharm Fr; 2011 Sep; 69(5):270-6. PubMed ID: 21924128 [TBL] [Abstract][Full Text] [Related]
13. [Shelf life of some injection solutions that are frequently replicated in interhospital pharmacies]. Proshunina DV; Gubiĭ NA; Fleĭsh NL; Gropianova TM; Zelepukhin VP Farm Zh; 1976; 31(1):84-90. PubMed ID: 1269730 [No Abstract] [Full Text] [Related]
14. A study of some factors affecting the in-vitro release of drug from prolonged release granulations. 1. Effect of method of preparation. Asker AF; Motawi AM; Abdel-Khalek MM Pharmazie; 1971 Mar; 26(3):170-2. PubMed ID: 5574493 [No Abstract] [Full Text] [Related]
15. Effects of compounding and storage conditions on stability of pergolide mesylate. Davis JL; Kirk LM; Davidson GS; Papich MG J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262 [TBL] [Abstract][Full Text] [Related]